Petra Pharma

Commercializing research from Weill Cornell Medicine to develop therapies for cancer and metabolic diseases.


As part of the Accelerator Life Science partnership, the Partnership Fund and the state’s Innovate NY program invested in Petra as part of its initiative to grow life sciences.


Petra is developing small molecules for the treatment of cancer and metabolic diseases. Spun out of Dr. Lewis C. Cantley’s lab at Weill Cornell Medicine.

Visit site